Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia

被引:57
作者
De Luigi, A
Pizzimenti, S
Quadri, P
Lucca, U
Tettamanti, M
Fragiacomo, C
De Simoni, MG
机构
[1] Mario Negri Inst Pharmacol Res, Lab Inflammat & Nervous Syst Dis, Dept Neurosci, I-20157 Milan, Italy
[2] Beata Vergine Reg Hosp, Div Geriatr, Mendrisio, Switzerland
[3] Beata Vergine Reg Hosp, Ctr Malattie Lipidemiche & Dismetab, Mendrisio, Switzerland
关键词
cytokines; Alzheimer's disease; multiinfarct dementia; inflammation;
D O I
10.1006/nbdi.2002.0556
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Whether peripheral inflammatory molecules can be considered markers of dementia is still an open issue. We have investigated the presence of circulating cytokines and the ability of blood cells to release them in response to an inflammatory stimulus in patients with different types of dementia and in age-matched controls. A significant increase in circulating interleukin-1beta in moderate Alzheimer and in multilinfarct (145 and 224 times control concentration, respectively) dementia and in circulating tumor necrosis factor-a concentration in multlinfarct dementia patient group (156%) were found. Tumor necrosis factor-alpha and interleukin-6 released from blood cells after exposure to lipopolysaccharide were significantly reduced in moderate Alzheimer (60%, both cytokines) and multiiinfarct patients (71 and 50%, respectively), while interieukin-10 was decreased only in multiinfarct patients (61%). The results show that patients with Alzheimer disease or multiiinfarct dementia have an upregulation of circulating cytokines and a downregulation of cytokines released by blood cells. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:308 / 314
页数:7
相关论文
共 40 条
[31]   The role of TNF and its receptors in Alzheimer's disease [J].
Perry, RT ;
Collins, JS ;
Wiener, H ;
Acton, R ;
Go, RCP .
NEUROBIOLOGY OF AGING, 2001, 22 (06) :873-883
[32]   A double-blind, placebo-controlled trial of diclofenac misoprostol in Alzheimer's disease [J].
Scharf, S ;
Mander, A ;
Ugoni, A ;
Vajda, F ;
Christophidis, N .
NEUROLOGY, 1999, 53 (01) :197-201
[33]   Circulating cytokines in Alzheimer's disease [J].
Singh, VK ;
Guthikonda, P .
JOURNAL OF PSYCHIATRIC RESEARCH, 1997, 31 (06) :657-660
[34]   Intracerebral production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementia [J].
Tarkowski, E ;
Blennow, K ;
Wallin, A ;
Tarkowski, A .
JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (04) :223-230
[35]   Interleukin-6, tumor necrosis factor and corticosterone induction by central lipopolysaccharide in aged rats [J].
Terrazzino, S ;
Perego, C ;
DeLuigi, A ;
DeSimoni, MG .
LIFE SCIENCES, 1997, 61 (07) :695-701
[36]   Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques [J].
Wallace, MN ;
Geddes, JG ;
Farquhar, DA ;
Masson, MR .
EXPERIMENTAL NEUROLOGY, 1997, 144 (02) :266-272
[37]   Induction of cytokine receptors by glucocorticoids: functional and pathological significance [J].
Wiegers, GJ ;
Reul, JMHM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (08) :317-321
[38]   CYTOKINE INDEXES IN ALZHEIMERS TEMPORAL CORTEX - NO CHANGES IN MATURE IL-1-BETA OR IL-1RA BUT INCREASES IN THE ASSOCIATED ACUTE-PHASE PROTEINS IL-6, ALPHA-2-MACROGLOBULIN AND C-REACTIVE PROTEIN [J].
WOOD, JA ;
WOOD, PL ;
RYAN, R ;
GRAFFRADFORD, NR ;
PILAPIL, C ;
ROBITAILLE, Y ;
QUIRION, R .
BRAIN RESEARCH, 1993, 629 (02) :245-252
[39]   Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease [J].
Xia, MQ ;
Hyman, BT .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (01) :32-41
[40]   Up-regulated production and activation of the complement system in Alzheimer's disease brain [J].
Yasojima, K ;
Schwab, C ;
McGeer, EG ;
McGeer, PL .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (03) :927-936